Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPTH
DataOraFonteTitoloSimboloCompagnia
19/03/202512:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
18/03/202512:00GlobeNewswire Inc.Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes PatientsNASDAQ:BPTHBio Path Holdings Inc
14/02/202523:26Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BPTHBio Path Holdings Inc
13/02/202522:01GlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
13/02/202514:00GlobeNewswire Inc.Bio-Path Holdings Provides Key Clinical UpdatesNASDAQ:BPTHBio Path Holdings Inc
12/02/202522:01GlobeNewswire Inc.Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid LeukemiaNASDAQ:BPTHBio Path Holdings Inc
12/02/202516:59Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BPTHBio Path Holdings Inc
21/01/202512:10Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
10/01/202513:00GlobeNewswire Inc.Bio-Path Holdings Provides 2025 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
19/12/202413:00GlobeNewswire Inc.Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin SensitivityNASDAQ:BPTHBio Path Holdings Inc
11/12/202413:00GlobeNewswire Inc.Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes PatientsNASDAQ:BPTHBio Path Holdings Inc
15/11/202413:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
13/11/202417:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
08/11/202413:00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024NASDAQ:BPTHBio Path Holdings Inc
28/10/202421:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BPTHBio Path Holdings Inc
28/10/202421:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
28/10/202421:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
23/10/202413:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
23/10/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
22/10/202421:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BPTHBio Path Holdings Inc
18/10/202423:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
17/10/202422:37Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
10/10/202423:24GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
09/10/202402:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
08/10/202413:00GlobeNewswire Inc.Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of ObesityNASDAQ:BPTHBio Path Holdings Inc
16/09/202413:00GlobeNewswire Inc.Bio-Path Holdings Announces Publication in BiomedicinesNASDAQ:BPTHBio Path Holdings Inc
03/09/202413:00GlobeNewswire Inc.Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BPTHBio Path Holdings Inc
21/08/202413:00GlobeNewswire Inc.Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid TumorsNASDAQ:BPTHBio Path Holdings Inc
15/08/202413:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/08/202422:41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPTH